Inactive Instrument

Medgenics, Inc. Share Price NYSE

US58436Q2030

Biotechnology & Medical Research

End-of-day quote NYSE Other stock markets
- ^USD	-

04/02/20	Aevi Genomic Medicine, LLC(NasdaqGM:GNMX) dropped from S&P TMI Index	CI
03/02/20	Aevi Genomic Medicine, Inc. Announces Resignation of Directors	CI

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The Company's product candidates include AEVI-001 and AEVI-002. The Company's research and development efforts leverage an internal genomics platform and a collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). .

Employees

Sector

Biotechnology & Medical Research

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

04/02/20	Aevi Genomic Medicine, LLC(NasdaqGM:GNMX) dropped from S&P TMI Index	CI
03/02/20	Aevi Genomic Medicine, Inc. Announces Resignation of Directors	CI
03/02/20	Aevi Genomic Medicine, LLC(NasdaqCM:GNMX) dropped from NASDAQ Composite Index	CI
02/02/20	Cerecor Inc. completed the acquisition of Aevi Genomic Medicine, Inc..	CI
22/11/19	Aevi Genomic Medicine, Inc. Doses the First Patient with AEVI-002 in A Phase Ib Clinical Trial	CI
14/11/19	Aevi Genomic Medicine, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	CI
13/11/19	Cerecor Inc. entered into a definitive merger agreement to acquire Aevi Genomic Medicine, Inc. for $15.6 million.	CI
13/08/19	Aevi Genomic Medicine, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	CI
07/08/19	Aevi Genomic Medicine, Inc. Obtains License for Medi2338, Phase 2-Ready Fully Human Monoclonal Antibody That Targets Interleukin 18 (IL-18)	CI
24/06/19	Declaration of Voting Results by Aevi Genomic Medicine, Inc.	CI
21/05/19	Aevi Genomic Medicine, Inc. Announces Executive Changes	CI
14/05/19	Aevi Genomic Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	CI
29/03/19	The Children’s Hospital Nominates Board Candidate to Aevi Genomic	CI

03/02/20	AEVI GENOMIC MEDICINE, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
23/12/19	AEVI GENOMIC MEDICINE, INC. : Unregistered Sale of Equity Securities, Regulation FD Disclosure, Other Events (form 8-K)	AQ
11/12/19	AEVI GENOMIC MEDICINE : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K/A)	AQ
10/12/19	AEVI GENOMIC MEDICINE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
05/12/19	AEVI GENOMIC MEDICINE, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-0.89%	+1.75%	+4.62%	+15.58%	49.54B
REVOLUTION MEDICINES, INC.	-0.69%	+6.25%	+492.36%	+585.40%	44.06B
BEONE MEDICINES AG	+0.08%	+11.23%	+23.99%	+81.74%	40.85B
IQVIA HOLDINGS INC.	+0.76%	+6.85%	+35.40%	+10.92%	40.14B
CELLTRION, INC.	+4.73%	+13.29%	+27.76%	+54.22%	34.17B
ASCENDIS PHARMA A/S	-0.41%	+4.08%	-	-	16.78B
MEDPACE HOLDINGS, INC.	+0.51%	+5.29%	+34.62%	+126.87%	16.9B
EUROFINS SCIENTIFIC SE	-0.20%	+0.11%	+4.46%	+20.99%	14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.81%	+20.45%	+89.35%	+31.49%	13.46B
Average	+0.65%	+283.80%	+89.07%	+115.90%	29.99B
Weighted average by Cap.	+0.56%	+296.87%	+107.15%	+138.49%

Medgenics, Inc. Share Price NYSE

Stocks

US58436Q2030

Biotechnology & Medical Research

Latest news : Medgenics, Inc.

Press Releases: Medgenics, Inc.

Other Biotechnology & Medical Research

Company Profile